Evans-Brown, M; Ujváry, I; De Morais, J; Christie, R; Almeida, A; Jorge, R; Gallegos, A; Sedefov, R. EMCDDA technical report on the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene), 1 Jan 2020. 829 kB. #Metonitazene
Vandeputte, MM; Van Uytfanghe, K; Layle, NK; Germaine, DMS; Iula, DM; Stove, CP. Synthesis, chemical characterization, and μ-opioid receptor activity assessment of the emerging group of “Nitazene” 2-benzylbenzimidazole synthetic opioids ACS Chem. Neurosci., 7 Apr 2021, 12 (7), 1241–1251. 12.5 MB. https://doi.org/10.1021/acschemneuro.1c00064 #Metonitazene LC,MS,NMR
Ujváry, I; Christie, R; Evans-Brown, M; Gallegos, A; Jorge, R; de Morais, J; Sedefov, R. DARK classics in chemical neuroscience: Etonitazene and related benzimidazoles ACS Chem. Neurosci., 7 Apr 2021, 12 (7), 1072–1092. 2.0 MB. https://doi.org/10.1021/acschemneuro.1c00037 #8
Kanamori, T; Okada, Y; Segawa, H; Yamamuro, T; Kuwayama, K; Tsujikawa, K; Iwata, YT. Analysis of highly potent synthetic opioid nitazene analogs and their positional isomers Drug Test. Anal., 1 Apr 2023, 15 (4), 449–457. 634 kB. https://doi.org/10.1002/dta.3415 #MetN GC,LC,MS,NMR,IR
Hasegawa, K; Minakata, K; Suzuki, M; Suzuki, O. Non-fentanyl-derived synthetic opioids emerging during recent years Forensic Toxicol., 1 Jul 2022, 40 (2), 234–243. 1.6 MB. https://doi.org/10.1007/s11419-022-00624-y #Table S2 (5)